ArticleScientific reports2026
Genome editing-based refinement of GPCR visualization in mice using the oxytocin receptor as a model.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
G protein-coupled receptors (GPCRs) mediate diverse physiological functions and are major drug targets, yet their in vivo visualization remains challenging due to poor antigenicity. In this study, we integrate structural prediction, functional assay, and genome editing to systematically refine epitope-tagging strategies for GPCRs in mouse models. Using the oxytocin receptor (Oxtr) as a representative GPCR, we compare conventional triple-HA tagging with two recently developed high-sensitivity tags, Spaghetti Monster fluorescent protein (smFP) and the ALFA tag. Each tag is fused to the Oxtr C-terminus, and in vitro G protein activation assays show that all three variants retain ~ 70% of wild-type activity, consistent with structural predictions from AlphaFold 3. We then generate knock-in mice employing genome editing to evaluate in vivo performance. smFP markedly improves the signal-to-noise ratio in tissue staining, whereas the ALFA tag disrupts trafficking without enhancing sensitivity. Primary cultured neurons derived from smFP knock-in mice clearly visualize the distribution of Oxtr along dendrites down to their terminals at subcellular resolution. Collectively, the refined animal models advance GPCR biology and inform the design of future genome editing approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.